Rhea-AI Summary
Summary not available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.1%
Tags
-
Rhea-AI Summary
Summary not available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.1%
Tags
-
Rhea-AI Summary
Alpha Healthcare Acquisition Corp. III (NASDAQ: ALPA) has entered a definitive business combination agreement with Carmell Therapeutics Corporation, a Phase 2-stage biotech firm specializing in allogeneic plasma-based biomaterials for tissue healing. Post-transaction, ALPA will be renamed as Carmell and is expected to have a market cap of approximately $328 million. With 15 million shares exchanged, existing Carmell shareholders will own about 46% of the Combined Company. The deal aims to leverage Carmell's innovative technology to improve patient outcomes and reduce costs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.6%
Tags
FAQ
What is the market cap of ALPA (ALPA)?
The market cap of ALPA (ALPA) is approximately 193.7M.